跳至主要内容
临床试验/CTRI/2010/091/000389
CTRI/2010/091/000389招募中3 期

A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL (RBS8020) IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSIO

Adani Wilmar Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male or Female > or = 18 yrs of age.
  • DM diagnosed at least 3 months prior to screening.
  • HT diagnosed at least 1 month prior to screening
  • The subject should have HbA1c > or = 7.0 % and < or = 11.5 % on screening
  • The subject should have msDBP > or = 85 mm Hg and <110 mm Hg on screening.
  • The subject should be on a stable dose of OHAs and anti hypertensive for 1 month prior to screening.
  • If patient is on lipid lowering agents, therapy should be stable for 1 month prior to screening
  • Body Mass Index > or = 20 kg/m2 and < or = 45 kg/m2.
  • Subject should be capable of understanding and complying with protocol
  • requirements.
  • Subject or the subject`s legally acceptable representative signs a written, informed consent form prior to initiation of any study procedure.
  • No major illness or debility that in the investigator`s opinion prohibits the subject from completing the study.

排除标准

  • History / Evidence of allergy or hypersensitivity to any edible oils used for preparing food.
  • Subjects receiving Insulin for treatment of DM.
  • History of a psychiatric disorder that will affect the subject`s ability to participate in the study.
  • History of alcohol or substance abuse within the 2 years prior to screening.
  • History of treatment with any weight loss drugs or oral or systemically injected steroids within 3 months prior to screening.
  • Receipt of any investigational drug within the 30 days prior to screening.
  • Prior treatment in an investigational study of any edible oil used for preparing food.
  • Subject is a study site employee, or is an immediate family member of a study site employee who is involved in the conduct of this study.
  • Systolic blood pressure > 180 mm Hg and / or diastolic pressure >110 mm Hg.
  • Lab values for exclusion:
  • Serum Triglycerides >500 mg/dl LDL Cholesterol- >200 mg/dl FBS- <110 mg/dl and >240 mg/dl
  • History of any haemoglobinopathy that may affect determination of HbA1c.
  • Patient has had any of the following within the past 12 months.
  • a) Acute coronary syndrome (e.g. : MI or unstable angina)
  • b) Coronary artery intervention (CABG or PTCA)
  • c) Stroke or transient ischemic neurological disorder.
  • Patient has congestive cardiac failure or a history of congestive heart failure.
  • Subject with any significant ECG abnormalities
  • Subject with any life threatening illness or any history of cancer or malignancy.
  • History of any serological abnormality or infection with HIV.
  • Subject on use of antioxidants or omega 3 supplements.

研究者

发起方
Adani Wilmar Ltd

相似试验